Exogenous and endogenous opioids as biological response modifiers
- 30 November 1995
- journal article
- research article
- Published by Elsevier in Immunopharmacology
- Vol. 31 (1) , 59-71
- https://doi.org/10.1016/0162-3109(95)00033-6
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced diseaseInternational Journal of Immunopharmacology, 1994
- Increased Replication of Simian Immunodeficiency Virus in CEM x174 Cells by Morphine SulfateBiochemical and Biophysical Research Communications, 1993
- Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: Risk factors for infectious diseaseLife Sciences, 1991
- Effects of opioid peptides on the cellular immunity in spleen cells from intact nude mice or nude mice bearing human ovarian carcinomaCancer Immunology, Immunotherapy, 1990
- Antitumor activity of enkephalin analogues in inhibiting PYB6 tumor growth in mice and immunological effects of methionine enkephalinamideInternational Journal of Immunopharmacology, 1989
- Methionine-enkephalin and β-endorphin levels in spleen and thymus gland of morphine tolerant-dependent and abstinent ratsLife Sciences, 1989
- Expression of Opioid Peptides in TumorsNew England Journal of Medicine, 1987
- Endorphins stimulate normal human peripheral blood lymphocyte natural killer activityLife Sciences, 1984
- B-endorphin modulates human immune activity via non-opiate receptor mechanismsLife Sciences, 1982
- Effects of certain abused drugs on hemolysin forming cellsLife Sciences, 1975